Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Issue title: Similarities and Differences Between Mild Cognitive Impairment and Alzheimer's Disease
Article type: Research Article
Authors: Markesbery, William R.; *
Affiliations: Departments of Pathology and Laboratory Medicine, and Neurology, Sanders-Brown Center on Aging, and Alzheimer's Disease Center, University of Kentucky College of Medicine, University of Kentucky, Lexington, Kentucky, USA | Sanders-Brown Center on Aging and Alzheimer's Disease Center, Department of Chemistry, University of Kentucky, Lexington, Kentucky, USA
Correspondence: [*] Address for correspondence: William R. Markesbery, M.D., Departments of Pathology and Laboratory Medicine, and Neurology, Sanders-Brown Center on Aging, and Alzheimer's Disease Center, University of Kentucky College of Medicine, University of Kentucky, 101 Sanders-Brown Building, 800 S. Limestone Street, Lexington, KY 40536-0230, USA. Tel.: +1 859 323 6040; Fax: +1 859 323 2866; E-mail: [email protected].
Abstract: Mild cognitive impairment (MCI), the earliest clinically detectable phase of the trajectory toward dementia and Alzheimer's disease (AD), led to the need for even earlier detection and prevention of AD. Although it is a clinical diagnosis, its underlying neuropathological findings are just being defined. MCI is best studied in longitudinally followed patients in centers that are experienced in dementing disorders. In this review of the few major clinical-pathological reports of longitudinally followed patients, it appears that most autopsied amnestic MCI (aMCI) patients are on a pathway toward AD. Neurofibrillary pathology in entorhinal cortex, hippocampus, and amygdala – not amyloid plaques – is the major substrate for aMCI and for memory decline. In addition, many MCI patients have other concomitant pathological alterations, the most common of which are strokes, but also include argyrophilic grains and Lewy bodies. These findings are not surprising because most MCI autopsied cases have been in the older (80 to 90 year) range where these findings are common. In early AD, the phase following MCI, the significant change is an increase in neurofibrillary tangles in the neocortex that correlates with an increase in Braak score and the observed clinical progression.
Keywords: Alzheimer's disease, mild cognitive impairment, neurofibrillary tangles, preclinical Alzheimer's disease
DOI: 10.3233/JAD-2010-1220
Journal: Journal of Alzheimer's Disease, vol. 19, no. 1, pp. 221-228, 2010
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]